Results 61 to 70 of about 9,184,490 (148)

Influence of Selective Laser Trabeculoplasty (SLT) on the iStent inject® outcomes [PDF]

, 2020
Background: To evaluate the influence of Selective Laser Trabeculoplasty (SLT) on iStent inject® outcomes in open-angle glaucoma (OAG). Methods: In this retrospective comparative cohort outcome study, 66 patients who were treated with two iStent ...
Davids, Anja-Maria, Pilger, Daniel, Maier, Anna-Karina B., Arani, Parisa, Pahlitzsch, Milena, Klamann, Matthias K. J., Winterhalter, Sibylle   +6 more
core   +1 more source

The transition of BCVA: iStent eyes and inject W eyes.

The transition of BCVA: iStent eyes and inject W eyes.
Yoshihito Sakanishi (17904254), Nobuyuki Ebihara (805110), Shuu Morita (17904251), Satoshi Watanabe (103008), Ikari Riyu (17904257)   +4 more
core   +1 more source

Factors affecting cumulative survival: iStent eyes and inject W eyes.

Factors affecting cumulative survival: iStent eyes and inject W eyes.
Yoshihito Sakanishi (17904254), Nobuyuki Ebihara (805110), Shuu Morita (17904251), Satoshi Watanabe (103008), Ikari Riyu (17904257)   +4 more
core   +1 more source

IOP and glaucoma medication score: iStent eyes and inject W eyes.

IOP and glaucoma medication score: iStent eyes and inject W eyes.
Yoshihito Sakanishi (17904254), Nobuyuki Ebihara (805110), Shuu Morita (17904251), Satoshi Watanabe (103008), Ikari Riyu (17904257)   +4 more
core   +1 more source

Comparison of cumulative survival rates: iStent eyes vs. inject W eyes.

The cumulative survival rates at 6 and 12 months postoperatively for the iStent eyes were 83.6% and 66.0% and 84.0% and 78.4% for the inject W eyes, respectively. Log-rank test: p = 0.50.
Yoshihito Sakanishi (17904254), Nobuyuki Ebihara (805110), Shuu Morita (17904251), Satoshi Watanabe (103008), Ikari Riyu (17904257)   +4 more
core   +1 more source

Prospective unmasked randomized evaluation of the iStent inject (®) versus two ocular hypotensive agents in patients with primary open-angle glaucoma. [PDF]

, 2014
PURPOSE: The purpose of this study was to compare outcomes of subjects with open-angle glaucoma (OAG) not controlled on one medication who underwent either implantation of two iStent inject (®) trabecular micro-bypass devices or received medical therapy ...
Belda, Jose I, Jünemann, Anselm, Fea, Antonio M, Rękas, Marek, Chang, Lydia, Pablo, Luis, Voskanyan, Lilit, Katz, L Jay   +7 more
core   +2 more sources

Five-Year, Private Sector Cost Comparison of iStent inject® W, Trabeculectomy, Glaucoma Medications for Primary Open-Angle Glaucoma With and Without Phacoemulsification: A Filipino Patient Perspective

Philippine Journal of Ophthalmology
Objective: To perform a cost comparison of the 5-year total direct medical costs of iStent inject® W vs. trabeculectomy vs. glaucoma medications for the treatment of primary open-angle glaucoma, with and without phacoemulsification, from the perspective ...
Jose Ma Martinez, MD, Rommel Bautista, MD, Ivan Tecson, MD, Alice Chu, PhD, Sheena Suthen, BSc (Hons), David Champion, MPH (Hons), Anand Jha, MBA   +6 more
doaj  

Hydrus microstent versus triple iStent inject W combined with phacoemulsification for glaucoma management: three-year outcomes

Eye
Abstract The Hydrus Microstent (HM) and iStent inject W are two widely-used trans-trabecular bypass devices. Aim: To compare the efficacy and safety of the HM with triple iStent inject W (TiSW) combined with phacoemulsification, in a real-world setting.
Graham Lee, Shenouda Girgis
openaire   +5 more sources

Comparison of changes in IOP and medication score at 12 months postoperatively: iStent eyes vs inject eyes.

Comparison of changes in IOP and medication score at 12 months postoperatively: iStent eyes vs inject eyes.
Yoshihito Sakanishi (17904254), Nobuyuki Ebihara (805110), Shuu Morita (17904251), Satoshi Watanabe (103008), Ikari Riyu (17904257)   +4 more
core   +1 more source

Real-world comparison of efficacy and safety of XEN45 implant with phacoemulsification versus iStent inject® W with phacoemulsification

Journal Français d'Ophtalmologie
To compare iStent inject® W+phacoemulsification with XEN45 implant+phacoemulsification over 12 months in mild to moderate glaucoma patients needing cataract surgery at the Hospital General Universitario Dr. Balmis, Alicante, Spain.Retrospective clinical cohort study.
Mendoza-Moreira, Angi Lizbeth, Marcos-Parra, María Teresa, de Bari, Sergio, Ezbakhe, Jihane, España-Vera, Enrique, Calatayud-Hernández, María C., Perez-Santonja, Juan J.   +6 more
openaire   +2 more sources